Vyvanse
Compare with other ADHD Medications
Compare
| Vyvanse |
VS |
ADHD Medications |
|
|
Basic Information |
| Generic Name |
|
Lisdexamfetamine |
4.8% ADHD Medications have lisdexamfetamine |
| Class |
|
Cns Stimulants |
85.7% ADHD Medications have CNS Stimulants |
| Prescription Generic Available |
|
No |
33.3% ADHD Medications don't have Prescription Generic Available
|
| Pregnancy cat. |
|
C(US) |
85.7% ADHD Medications have C(US) |
| Approved Age |
|
6 And Older |
85.7% ADHD Medications have 6 and older
|
| Legal Status |
|
Pharmacist Only (au) Pom (uk) Schedule Ii (us) |
|
| Excretion |
|
Renal: ~2% |
5.3% ADHD Medications have Renal: ~2% |
| Possible Side Effects |
|
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
|
|
|
Dosage, Usage and Forms |
| Routes (of administration) |
|
Oral |
|
| Dosage |
|
30 Mg Q Am–70 Mg Q Am |
|
| Maximum daily dose |
|
|
|
| Duration |
|
Long-acting |
52.4% ADHD Medications have Long-acting
|
| Duration - time |
|
8-12 H |
19% ADHD Medications have 8-12 h
|
|
|
Chemical Data |
| Molecular mass (g/mol) |
|
263.378 G/mol |
|
| Half Life |
|
< 1 Hour (prodrug Molecule), 12-13 Hours (d-amphetamine) |
|
| Formula |
|
C15H25N3O |
|
| Bioavailability |
|
|
|
| Metabolism |
|
Gastro-intestinal (initial); Hepatic (extensively Cyp2d6) After Conversion To D-amphetamine |
|